Key result
This document is a list of editorial board members for the International Journal of Angiology and contains no clinical trial data.
Answers are grounded in this paper and cite their sources.
Surgical options enhance survival in heart failure patients, indicating critical interventions for care.
Heart failure (HF) continues to be a leading cause of morbidity and mortality. Despite optimized medical therapy (OMT), a significant portion of patients will progress to advanced stages of HF to which OMT is no longer sufficient. Myocardial revascularization remains a cornerstone for patients with ischemic cardiomyopathy, with evidence showing significant survival benefits over OMT alone. Valvular interventions address secondary mitral and aortic disease that contribute to declining cardiac function. For patients with end-stage failure or cardiogenic shock, mechanical circulatory support devices and ventricular-assist devices serve as bridge or destination therapy.
No takes yet. Share an insight, caveat, or question.
Stegall et al. (2026) studied Heart Failure. This document is a list of editorial board members for the International Journal of Angiology and contains no clinical trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: